PSA Medical Abbreviation: Prostate-Specific Antigen and What the Test Means
In medical records, PSA usually means prostate-specific antigen, a protein made by prostate cells. A PSA blood test measures how much of this protein is present in the blood.
PSA is used in prostate-cancer screening, evaluation and follow-up, but it is not a cancer diagnosis by itself. PSA can also rise with benign prostatic hyperplasia (BPH), prostatitis and other prostate conditions, so the number has to be interpreted in context.
PSA → prostate-specific antigen
Educational terminology guide: Medical-Terms.org is an independent dictionary website, not a clinic or laboratory. This page explains the PSA abbreviation and common test language; it cannot interpret an individual PSA result or decide whether someone should be screened.
What does PSA stand for in medical terms?
PSA stands for prostate-specific antigen. It is a protein made by prostate tissue. A PSA test measures the amount of PSA in the blood and may be used for prostate-cancer screening, evaluation of prostate-related concerns and monitoring after treatment. A high result can occur for cancerous and noncancerous reasons.
PSA is a protein, not the name of a disease
Prostate-specific antigen is produced by epithelial cells in normal as well as malignant prostate tissue. NLM MeSH classifies it as a glycoprotein, a kallikrein-like serine proteinase and a tumor biomarker.
The prostate is a gland in the male reproductive system located below the bladder. Most PSA is associated with prostate secretions, while a small amount can be measured in the bloodstream.
PSA protein
The abbreviation names a real biochemical substance made by prostate tissue.
PSA blood level
The laboratory test measures the concentration of PSA circulating in blood.
PSA result
The result is interpreted with age, symptoms, previous results, medicines and other clinical information.
What is a PSA test used for?
A PSA test measures prostate-specific antigen in a blood sample. According to NCI, the test can be used in several settings: screening people without prostate-cancer symptoms, evaluating prostate-related symptoms or concerns, and monitoring people who have already been diagnosed or treated for prostate cancer.
| Use | What PSA contributes | What it cannot do alone |
|---|---|---|
| Screening | May help identify people who need further evaluation for possible prostate cancer. | Cannot determine by itself whether cancer is present. |
| Symptom evaluation | May be considered alongside urinary symptoms, blood in urine or semen, pelvic/back pain and other findings. | Cannot identify the exact cause of symptoms. |
| After diagnosis | PSA trends can help monitor known prostate cancer. | A single result should not be interpreted without the treatment context. |
| After treatment | A rising PSA trend may be an early sign that warrants evaluation for recurrence. | One elevated measurement does not automatically prove recurrence. |
Does a high PSA mean prostate cancer?
No. A high PSA can occur with prostate cancer, but several noncancerous conditions can also raise the level. NCI and MedlinePlus specifically identify benign prostatic hyperplasia (BPH), prostatitis and other prostate problems as possible causes of elevated PSA.
Prostate cancer
Cancer can raise PSA, which is why the marker is used in screening, evaluation and follow-up.
BPH
Benign prostatic hyperplasia is noncancerous prostate enlargement and can increase PSA.
Prostatitis
Inflammation or infection involving the prostate can raise PSA temporarily.
| Factor | Possible effect on PSA | Why context matters |
|---|---|---|
| Prostate infection/inflammation | Can increase PSA | NCI notes the elevation can persist for weeks after the condition or a prostate biopsy. |
| Recent prostate biopsy | Can increase PSA temporarily | Timing of the blood draw may affect interpretation. |
| Ejaculation | May temporarily increase PSA | NCI advises avoiding activities that may raise PSA for about 2 days before testing when instructed. |
| Vigorous cycling/exercise | May transiently increase PSA | Recent activity should be considered if the result is unexpected. |
| Finasteride or dutasteride | Can lower PSA | Clinicians may interpret results differently when these medicines are being taken. |
Do not read one PSA number as a diagnosis. PSA is a biomarker. The reason it was ordered, prior results, prostate conditions, medicines and follow-up testing all affect what the result means.
What is a normal PSA level?
There is no single PSA threshold that perfectly separates “normal” from “abnormal,” and no PSA number proves that prostate cancer is present. NCI notes that PSA levels tend to rise with age and that laboratories and clinicians may use different reference approaches.
A value above 4.0 ng/mL has historically been treated as a reason for closer evaluation in many settings, but lower or higher cutoffs may be used depending on age, medicines, risk factors and the clinical situation. Prostate cancer can occur below 4.0 ng/mL, and many people above that level do not have cancer.
Total PSA
The standard PSA value commonly reported on a blood test. The result is generally expressed in ng/mL.
Free PSA
Measures PSA circulating unbound in blood. Clinicians may use free PSA or related calculations in selected cases when deciding whether further evaluation is useful.
PSA trend
Changes over time can matter, especially after prostate-cancer treatment. A clinician may look at repeated results rather than one isolated value.
PSA density / velocity
These are additional ways of relating PSA to prostate volume or change over time. They are specialist interpretation tools, not simple stand-alone pass/fail numbers.
Helpful question for a clinician: “Is this PSA result being compared with my age, prostate size, medicines and previous PSA values, and do I need a repeat test before any other step?”
PSA screening is a decision, not a universal routine test
Screening means testing a person who does not have symptoms. Major organizations differ in exactly when PSA screening should begin and how often it should be done because screening has both possible benefits and harms, including false-positive results, biopsy complications, overdiagnosis and overtreatment.
In the United States, the currently published USPSTF recommendation is from 2018 and is being updated. It says men ages 55–69 should make an individual decision about periodic PSA-based screening after discussing benefits and harms with a clinician, and recommends against routine PSA-based screening for men age 70 and older.
Potential benefit
Screening may detect some prostate cancers earlier, when treatment can be considered before disease spreads.
Potential harms
False positives can lead to anxiety and additional procedures, while overdiagnosis can identify cancers that may never have caused harm.
Shared decision
Age, family history, race/ethnicity, overall health, personal values and local clinical guidelines may affect the screening decision.
Guideline freshness: because the USPSTF prostate-cancer screening recommendation is currently under update, check the latest official recommendation before using age ranges as current personal screening advice.
What may happen after a high PSA result?
An elevated screening result usually does not lead directly to a cancer diagnosis. NCI notes that a clinician may first repeat the PSA test, especially when there is a possibility of temporary elevation. If PSA remains elevated or other findings are concerning, additional evaluation may follow.
Practical distinction: “elevated PSA,” “abnormal PSA,” and “prostate cancer” are not interchangeable terms. An elevated biomarker is a finding that may need explanation.
How PSA may appear in charts and lab reports
| Wording | Likely meaning | What to notice |
|---|---|---|
| “PSA ordered” | A blood test for prostate-specific antigen has been requested. | Why it was ordered: screening, symptoms, follow-up or monitoring. |
| “PSA 5.1 ng/mL” | The measured PSA concentration is 5.1 nanograms per milliliter. | Do not interpret the number without age, medications, previous results and clinical context. |
| “PSA rising” | Serial values are increasing over time. | Trend significance depends on why the person is being tested and whether they have had prostate-cancer treatment. |
| “Free PSA” | A measurement of unbound PSA in the bloodstream. | Usually interpreted with total PSA and other risk information. |
PSA vs PsA and other medical uses
In routine urology, oncology and general laboratory work, PSA overwhelmingly means prostate-specific antigen. However, capitalization and specialty still matter.
PSA
Prostate-specific antigen in urology, oncology and lab testing. This is the meaning covered by this article.
PsA
Psoriatic arthritis. The standard shorthand usually uses a lowercase “s,” so PsA and PSA should not be treated as the same abbreviation.
PSA in neurovascular literature
Posterior spinal artery may be abbreviated PSA in specialized anatomy, neurosurgery or spinal vascular papers.
Context shortcut: if the surrounding words mention a blood level, prostate, BPH, prostate cancer or urology, PSA almost certainly means prostate-specific antigen.
PSA medical abbreviation FAQs
What does PSA mean in medical terms?
PSA most commonly means prostate-specific antigen, a protein made by prostate tissue. A blood test can measure the amount of PSA in the bloodstream.
Is PSA a cancer test?
PSA is used in prostate-cancer screening, evaluation and follow-up, but it is not a cancer diagnosis by itself. Noncancerous prostate conditions can also raise PSA.
Does a high PSA always mean prostate cancer?
No. Benign prostatic hyperplasia, prostatitis, infection/inflammation, recent prostate procedures and other factors can raise PSA. A clinician may repeat the test or use additional evaluation to determine the cause.
What is considered a normal PSA?
There is no single PSA cutoff that perfectly separates normal from abnormal or cancer from noncancerous conditions. Age, medicines, prostate size, previous PSA values and other factors affect interpretation.
Is a PSA over 4 ng/mL cancer?
No. A value above 4.0 ng/mL has historically prompted closer evaluation in many settings, but many people above that level do not have prostate cancer, and cancer can occur below it.
What can temporarily raise PSA?
Prostate inflammation or infection, recent prostate biopsy, ejaculation and vigorous activities such as cycling can temporarily increase PSA in some people. Timing and recent events should be discussed with the clinician interpreting the test.
Can medicines change PSA?
Yes. NCI notes that drugs such as finasteride and dutasteride can lower PSA levels, so the prescribing and interpreting clinician should know that these medicines are being taken.
What happens if PSA is high?
A clinician may repeat the PSA test, review temporary causes and previous results, and consider additional blood or urine tests, prostate MRI or biopsy depending on the overall risk.
Is PsA the same as PSA?
No. PSA usually means prostate-specific antigen in medical testing. PsA, with a lowercase “s,” is commonly used for psoriatic arthritis.
Can PSA mean posterior spinal artery?
Yes, in specialized neuroanatomy or spinal vascular literature PSA can mean posterior spinal artery. In a prostate blood-test or urology context, PSA means prostate-specific antigen.
Authoritative sources used for this PSA definition
Review note: this page was refreshed on October 4, 2026. The primary abbreviation, PSA protein identity, MeSH code, test limitations, noncancerous causes of elevation and current U.S. screening-status note were checked against the sources above.